$AYTU
AYTU BIOPHARMA, INC Stock $aytu

$aytu Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000143774924034970 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$16.57M
YoY Change		-25.0%
Cost Of Revenue		$4.589M
YoY Change		-37.27%
Gross Profit		$11.99M
YoY Change		-18.93%
Gross Profit Margin		72.31%
Selling, General & Admin		$10.78M
YoY Change		-25.0%
% of Gross Profit		89.98%
Research & Development		$426.0K
YoY Change		-29.47%
% of Gross Profit		3.55%
Depreciation & Amortization		$1.427M
YoY Change		-36.01%
% of Gross Profit		11.91%
Operating Expenses		$12.92M
YoY Change		-20.71%
Operating Profit		-$930.0K
YoY Change		-38.16%
Interest Expense		$2.428M
YoY Change		-136.68%
% of Operating Profit
Other Income/Expense, Net		$542.0K
YoY Change		-108.19%
Pretax Income		$1.498M
YoY Change		-118.45%
Income Tax		$405.0K
% Of Pretax Income		27.04%
Net Earnings		$1.474M
YoY Change		-118.2%
Net Earnings / Revenue		8.89%
Basic Earnings Per Share		$0.24
Diluted Earnings Per Share		-$0.15
COMMON SHARES
Basic Shares Outstanding	6.149M	6.149M
Diluted Shares Outstanding		9.100M

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$20.11M
YoY Change		0.54%
Cash & Equivalents		$20.11M
Short-Term Investments
Other Short-Term Assets		$60.74M
YoY Change		8009.21%
Inventory		$11.74M
Prepaid Expenses		$5.732M
Receivables		$23.16M
Other Receivables		$0.00
Total Short-Term Assets		$60.74M
YoY Change		-13.97%
LONG-TERM ASSETS
Property, Plant & Equipment		$692.0K
YoY Change		-83.52%
Goodwill
YoY Change
Intangibles		$51.21M
YoY Change		-10.7%
Long-Term Investments
YoY Change
Other Assets		$1.971M
YoY Change		155.31%
Total Long-Term Assets		$55.09M
YoY Change		-11.55%
TOTAL ASSETS
Total Short-Term Assets		$60.74M
Total Long-Term Assets		$55.09M
Total Assets		$115.8M
YoY Change		-12.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$13.51M
YoY Change		-50.86%
Accrued Expenses		$33.72M
YoY Change		-17.2%
Deferred Revenue
YoY Change
Short-Term Debt		$4.270M
YoY Change		251.44%
Long-Term Debt Due		$1.857M
YoY Change		1757.0%
Total Short-Term Liabilities		$61.25M
YoY Change		-6.43%
LONG-TERM LIABILITIES
Long-Term Debt		$10.43M
YoY Change		-29.53%
Other Long-Term Liabilities		$4.921M
YoY Change		-39.29%
Total Long-Term Liabilities		$24.75M
YoY Change		205.37%
TOTAL LIABILITIES
Total Short-Term Liabilities		$61.25M
Total Long-Term Liabilities		$24.75M
Total Liabilities		$86.01M
YoY Change		-14.61%
SHAREHOLDERS EQUITY
Retained Earnings		-$318.5M
YoY Change		2.02%
Common Stock		$1.000K
YoY Change		-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$29.83M
YoY Change
Total Liabilities & Shareholders Equity		$115.8M
YoY Change		-12.84%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$1.474M
YoY Change		-118.2%
Depreciation, Depletion And Amortization		$1.427M
YoY Change		-36.01%
Cash From Operating Activities		-$1.190M
YoY Change		495.0%
INVESTING ACTIVITIES
Capital Expenditures		$136.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$517.0K
YoY Change		580.26%
Cash From Investing Activities		$381.0K
YoY Change		-601.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		911.0K
YoY Change		-133.32%
NET CHANGE
Cash From Operating Activities		-1.190M
Cash From Investing Activities		381.0K
Cash From Financing Activities		911.0K
Net Change In Cash		102.0K
YoY Change		-103.38%
FREE CASH FLOW
Cash From Operating Activities		-$1.190M
Capital Expenditures		$136.0K
Free Cash Flow		-$1.326M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	7900 East Union Avenue, Suite 920
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001385818
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	AYTU BIOPHARMA, INC
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6149202
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6149202
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5972638
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5972638
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	100000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2024Q3	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#DerivativeGainLossOnDerivativeNet
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	001-38247
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-0883144
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80237
CY2024Q3	dei	City Area Code CityAreaCode	720
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	437-6580
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q3	dei	Trading Symbol TradingSymbol	AYTU
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6149369
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20108000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20006000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23159000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23526000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	11739000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	12141000	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5732000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5097000	usd
CY2024Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2024Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1121000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	60738000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	61891000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	692000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	693000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1225000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	829000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	51205000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52453000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1971000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2185000	usd
CY2024Q3	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	44000	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	55093000	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	56204000	usd
CY2024Q3	us-gaap	Assets Assets	115831000	usd
CY2024Q2	us-gaap	Assets Assets	118095000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	13513000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	10314000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	33723000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38143000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	4270000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	2395000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1857000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1857000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7889000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8962000	usd
CY2024Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2024Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	557000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	61252000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	62228000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10430000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10877000	usd
CY2024Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	9402000	usd
CY2024Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12745000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4921000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4529000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	24753000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	28151000	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	348324000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	347688000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-318499000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-319973000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	29826000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	27716000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	115831000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118095000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16574000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17817000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4589000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4779000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	11985000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	13038000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5659000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6091000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5125000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6295000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	426000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	595000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	921000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	924000	usd
CY2024Q3	us-gaap	Restructuring Charges RestructuringCharges	784000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	12915000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	13905000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-930000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-867000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	542000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	584000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	994000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1283000	usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2880000	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5907000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1498000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7473000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	405000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1093000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7473000	usd
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	381000	usd
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-647000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	1474000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8120000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6068019
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5482037
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9099601
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5482037
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.18
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.36
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.2
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.36
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.06
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.12
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.04
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.12
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.48
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.48
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	27716000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	173000	usd
CY2024Q3	aytu	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	463000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	1474000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	29826000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	39357000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	930000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8120000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	32167000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1474000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8120000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1427000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1843000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	173000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	725000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2880000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5907000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	27000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	148000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	68000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	51000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	468000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	6000	usd
	aytu	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Discontinued Operations AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInDiscontinuedOperations	-157000	usd
	aytu	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Discontinued Operations AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInDiscontinuedOperations	592000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-478000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1684000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-334000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1121000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-119000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-467000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3143000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	946000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4969000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4827000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-101000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3744000	usd
	aytu	Increase Decrease In Operating Capital Attributable To Discontinued Operations IncreaseDecreaseInOperatingCapitalAttributableToDiscontinuedOperations	60000	usd
	aytu	Increase Decrease In Operating Capital Attributable To Discontinued Operations IncreaseDecreaseInOperatingCapitalAttributableToDiscontinuedOperations	-1124000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1190000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-211000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	517000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	136000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	-0	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-0	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	76000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	381000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1875000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-348000	usd
	aytu	Payments Of Fixed Payment Arrangements PaymentsOfFixedPaymentArrangements	500000	usd
	aytu	Payments Of Fixed Payment Arrangements PaymentsOfFixedPaymentArrangements	2204000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	160000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	464000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	22000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	911000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2734000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	102000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3021000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20006000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22985000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20108000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19964000	usd
	us-gaap	Interest Paid Net InterestPaidNet	366000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1359000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	446000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	246000	usd
	aytu	Other Noncash Investing And Financing Items OtherNoncashInvestingAndFinancingItems	483000	usd
	aytu	Other Noncash Investing And Financing Items OtherNoncashInvestingAndFinancingItems	0	usd
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><i><b>Use of Estimates</b></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The preparation of financial statements and footnotes requires the use of management estimates, judgments and assumptions. Actual results <em style="font: inherit;"> may </em>differ from estimates. In the accompanying unaudited consolidated financial statements and notes thereto, estimates are used for, but <em style="font: inherit;">not</em> limited to, stock-based compensation; revenue recognition, determination of variable consideration for accruals of chargebacks, administrative fees and rebates, government rebates, returns and other allowances; allowance for credit losses; inventory impairment; determination of right-of-use (“ROU”) assets and lease liabilities; valuation of financial instruments, warrants and derivative warrant liabilities, intangible assets, and long-lived assets; purchase price allocations and the depreciable lives of long-lived assets; accruals for contingent liabilities; and determination of the income tax provision, deferred taxes and valuation allowance. Because of the uncertainties inherent in such estimates, actual results <em style="font: inherit;"> may </em>differ from those estimates. The Company periodically evaluates estimates used in the preparation of the financial statements for reasonableness.</p>
CY2024Q3	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><i><b>Prior Period Reclassification</b></i></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Certain prior year amounts in the Company’s unaudited consolidated financial statements and the notes thereto have been reclassified to conform to the current year presentation. These reclassifications did <em style="font: inherit;">not</em> impact operating results or cash flows for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2024, </em>and <em style="font: inherit;">2023</em>, or the Company’s financial position as of <em style="font: inherit;"> September 30, 2024</em>, or <em style="font: inherit;"> June 30, 2024</em>.</p>
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27	pure
CY2024Q1	aytu	Employee Retention Credit Vendor Fee EmployeeRetentionCreditVendorFee	400000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	3300000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	3300000	usd
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown	100000	usd
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	720000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	266000	usd
CY2024Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3363000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5725000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7656000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6150000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	11739000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	12141000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2557000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2818000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1865000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2125000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	692000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	693000	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	100000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	300000	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	213000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	398000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1225000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	829000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	484000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	712000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1144000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	577000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1628000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1289000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M12D
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.111	pure
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	168000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	360000	usd
CY2024Q3	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	usd
CY2023Q3	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1000	usd
CY2024Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2023Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	23000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	792000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	399000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	377000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	386000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	358000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	230000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	19000	usd
CY2024Q3	aytu	Lessee Operating Lease Liability To Be Paid Including Lease Not Yet Commenced LesseeOperatingLeaseLiabilityToBePaidIncludingLeaseNotYetCommenced	2561000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	520000	usd
CY2024Q3	aytu	Lessee Operating Lease Liability Tenant Improvement Allowance LesseeOperatingLeaseLiabilityTenantImprovementAllowance	413000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1628000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	71468000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20263000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	51205000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P11Y10M24D
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	71468000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19015000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52453000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P12Y
CY2024Q3	aytu	Amortization Expense Of Intangible Assets AmortizationExpenseOfIntangibleAssets	1200000	usd
CY2023Q3	aytu	Amortization Expense Of Intangible Assets AmortizationExpenseOfIntangibleAssets	1500000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3742000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4989000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4989000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4989000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4989000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2847000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	24660000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	51205000	usd
CY2024Q3	aytu	Accrued Saving Offers AccruedSavingOffers	9929000	usd
CY2024Q2	aytu	Accrued Saving Offers AccruedSavingOffers	11054000	usd
CY2024Q3	aytu	Accrued Program Related Liabilities AccruedProgramRelatedLiabilities	5990000	usd
CY2024Q2	aytu	Accrued Program Related Liabilities AccruedProgramRelatedLiabilities	9964000	usd
CY2024Q3	aytu	Accrued Customer And Product Related Fees Current AccruedCustomerAndProductRelatedFeesCurrent	5540000	usd
CY2024Q2	aytu	Accrued Customer And Product Related Fees Current AccruedCustomerAndProductRelatedFeesCurrent	5395000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5212000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4603000	usd
CY2024Q3	aytu	Return Reserve Current ReturnReserveCurrent	4218000	usd
CY2024Q2	aytu	Return Reserve Current ReturnReserveCurrent	4832000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2834000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2295000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	33723000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38143000	usd
CY2024Q3	aytu	Fixed Payment Arrangements FixedPaymentArrangements	7405000	usd
CY2024Q2	aytu	Fixed Payment Arrangements FixedPaymentArrangements	8337000	usd
CY2024Q3	aytu	Employee Retention Credit EmployeeRetentionCredit	3759000	usd
CY2024Q2	aytu	Employee Retention Credit EmployeeRetentionCredit	3759000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1628000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1289000	usd
CY2024Q3	us-gaap	Other Sundry Liabilities OtherSundryLiabilities	18000	usd
CY2024Q2	us-gaap	Other Sundry Liabilities OtherSundryLiabilities	106000	usd
CY2024Q3	us-gaap	Other Liabilities OtherLiabilities	12810000	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	13491000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7889000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8962000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4921000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4529000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	12536000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13000000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	249000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	266000	usd
CY2024Q3	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	12287000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	12734000	usd
CY2024Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1857000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1857000	usd
CY2024Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10430000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10877000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1393000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1857000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1857000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7429000	usd
CY2024Q3	aytu	Long Term Debt And Capital Lease Obligations Gross LongTermDebtAndCapitalLeaseObligationsGross	12536000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	249000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1857000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10430000	usd
CY2024Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	9402000	usd
CY2024Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	9402000	usd
CY2024Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12745000	usd
CY2024Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	12745000	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	146539
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.18
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5100
CY2024Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.18
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	141439
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.25
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	63059
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.32
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y4M24D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	173000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	930000	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6075880
CY2024	aytu	Class Of Warrant Or Right Weighted Average Remaining Contractual Life ClassOfWarrantOrRightWeightedAverageRemainingContractualLife	P3Y7M6D
CY2024Q3	aytu	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	176000
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5899880
CY2024Q3	aytu	Class Of Warrant Or Right Weighted Average Remaining Contractual Life ClassOfWarrantOrRightWeightedAverageRemainingContractualLife	P3Y3M18D
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1093000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7473000	usd
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	381000	usd
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-647000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1474000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8120000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6068019
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5482037
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.18
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.36
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.06
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.12
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.48
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1093000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7473000	usd
CY2024Q3	us-gaap	Dilutive Securities DilutiveSecurities	-2880000	usd
CY2023Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q3	aytu	Adjusted Income Loss From Continuing Operations Diluted AdjustedIncomeLossFromContinuingOperationsDiluted	-1787000	usd
CY2023Q3	aytu	Adjusted Income Loss From Continuing Operations Diluted AdjustedIncomeLossFromContinuingOperationsDiluted	-7473000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6068019
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5482037
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3028862
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2720
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9099601
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5482037
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.2
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.36
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	381000	usd
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-647000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6068019
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5482037
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3028862
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2720
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9099601
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5482037
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.04
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.12
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	1474000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8120000	usd
CY2024Q3	us-gaap	Dilutive Securities DilutiveSecurities	-2880000	usd
CY2023Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1406000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8120000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6068019
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5482037
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3028862
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2720
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9099601
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5482037
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.48
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	626800
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6750854

Files In Submission

Name	View Source	Status
aytu-20240930_cal.xml	Edgar Link	unprocessable
0001437749-24-034970-index-headers.html	Edgar Link	pending
0001437749-24-034970-index.html	Edgar Link	pending
0001437749-24-034970.txt	Edgar Link	pending
0001437749-24-034970-xbrl.zip	Edgar Link	pending
aytu-20240930.xsd	Edgar Link	pending
aytu20231231_10qimg001.jpg	Edgar Link	pending
aytu20240930_10q.htm	Edgar Link	pending
ex_722660.htm	Edgar Link	pending
ex_722661.htm	Edgar Link	pending
ex_722662.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
aytu-20240930_def.xml	Edgar Link	unprocessable
aytu-20240930_lab.xml	Edgar Link	unprocessable
aytu-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aytu20240930_10q_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AYTU
AYTU BIOPHARMA, INC Stock $aytu

2024 Q4 Form 10-Q Financial Statement

#000143774924034970 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU AYTU BIOPHARMA, INC Stock $aytu

2024 Q4 Form 10-Q Financial Statement

#000143774924034970 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU
AYTU BIOPHARMA, INC Stock $aytu